What is NIAGEN?
NIAGEN is the first and only commercially available form of Nicotinamide Riboside (NR). It is the product of decades of groundbreaking scientific research conducted by ProHealthSpan's Chief Scientist, Charles Brenner, PhD.
- Repairs DNA damage
- Defends against free radicals
- Controls cellular metabolism
- Regulates our "longevity" genes
Nicotinamide Riboside (NR)
Charles Brenner, PhD is the world's foremost authority on NAD+. He is Head of Biochemistry and Professor of Internal Medicine at the University of Iowa, and co-founder of ProHealthspan, LLC.
Basis undergoes rigorous third party testing to confirm its content accurately reflects the ingredients listed on our label. Two capsules of Basis in our current lot contain 115% of promised quantity of NR, 112% of promised quantity of Pterostilbene.
Through our established laboratory model, Basis meets standard measures of safety and tolerability. Both primary ingredients in Basis are GRAS (generally recognized as safe) under intended conditions of use by qualified experts.
Subtle changes in overall feeling of well-being, sleep quality, energy consistency, cognitive function, and skin health are often reported within 4-16 weeks of starting. Note that cellular health may not always manifest results at the surface.
Basis is created in the United States in adherence with the FDA's Good Manufacturing Practices.
Administering NR for NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice.
By elevating NAD+, supplementation with NR promotes resistance to diet-induced obesity.
NR greatly reduced blood glucose, weight gain, liver damage and the development of hepatic steatosis in prediabetic and type 2 diabetic mice while protecting against sensory neuropathy.
In a mouse model of Alzheimer's, mice treated with NR performed better at cognitive tests.